Zydus MedTech (France) SAS has an authorised share capital of €1,000 and a paid-up share capital of €100. The subsidiary is currently an investment company with the immediate objective of acquiring the equity shares of Amplitude Surgical. Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences, has subscribed to 1,000 equity shares of Zydus MedTech (France) SAS for a total consideration of €1,000, including a share capital of €100 and an issuance premium of €900.
